Dashboard
Manage Tickers

PALI


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

palisade-bio-secures-canadian-patent-for-pali-2108-gut-activated-pde4-bd-inhibitor-targeting-fscd-and-uc
Palisade Bio Secures Canadian Patent For P...
10/13/2025 12:49:01

PALI-2108 is the first and only PDE4 inhibitor designed to target terminal ileum and colon for fibrostenotic Crohn's diseas...

steven-cohen-doubles-the-sp-500--and-his-next-bets-all-gut
Steven Cohen Doubles The S&P 500 — And His...
10/08/2025 15:30:40

Steven Cohen's Point72 Asset Management has doubled the S&P 500's three-year return and is investing in this biotec...

why-amd-shares-are-trading-higher-by-over-34-here-are-20-stocks-moving-premarket
Why AMD Shares Are Trading Higher By Over ...
10/06/2025 13:01:08

Core News & Articles
12 Health Care Stocks Moving In Monday's P...
10/06/2025 12:08:40

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
10/03/2025 12:08:34

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
10/02/2025 17:06:31

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
10/02/2025 12:09:25

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
10/01/2025 17:06:01

palisade-bio-prices-120m-public-offering-of-171440559-shares-at-070share
Palisade Bio Prices $120M Public Offering ...
10/01/2025 13:21:04

Palisade Bio, Inc.  (NASDAQ:PALI) ("Palisade" or the "Company"), a clinical-stage biopharmaceutical company foc...

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
10/01/2025 12:09:24

palisade-bio-adjourns-special-stockholder-meeting-due-to-lack-of-quorum
Palisade Bio Adjourns Special Stockholder ...
09/18/2025 20:08:56

palisade-bio-releases-pali-2108-phase-1b-clinical-data-demonstrating-100-clinical-response-regarding-efficacy-of-pali-2108-in-ulcerative-colitis
Palisade Bio Releases PALI-2108 Phase 1b C...
09/17/2025 13:05:46

PALI-2108 demonstrated favorable safety, with no serious adverse events, lab abnormalities, or EKG concernsPhase 1b data demons...

palisade-bio-receives-health-canada-clearance-to-initiate-phase-1b-study-of-pali-2108-in-fibrostenotic-crohns-disease
Palisade Bio Receives Health Canada Cleara...
09/05/2025 12:47:20

First dual-acting anti-inflammatory and anti-fibrotic candidate in development for FSCD, a condition with no approved therapies...

Core News & Articles
12 Health Care Stocks Moving In Monday's A...
08/11/2025 21:06:28

palisade-bio-reports-phase-1-results-for-pali-2108-showing-safety-and-strong-colon-tissue-drug-levels-as-company-prepares-for-phase-2-trial-in-2026
Palisade Bio Reports Phase 1 Results For P...
08/07/2025 13:16:47

PALI-2108 demonstrated to be safe and well tolerated with no serious adverse events (SAEs)Extended half-life and local bioactiv...

palisade-bio-secures-china-patent-for-pali-2108-a-targeted-pde4-inhibitor-for-crohns-disease-and-ulcerative-colitis
Palisade Bio Secures China Patent For PALI...
07/31/2025 12:46:19

PALI-2108 is the first and only PDE4 inhibitor designed to target terminal ileum and colon for fibrostenotic Crohn's diseas...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
07/24/2025 12:08:09

why-alphabet-shares-are-trading-higher-here-are-20-stocks-moving-premarket
Why Alphabet Shares Are Trading Higher; He...
07/24/2025 09:23:22

palisade-bio-raises-39m-through-exercise-of-43m-warrants-at-09047share-issues-86m-new-warrants-at-same-price
Palisade Bio Raises $3.9M Through Exercise...
07/24/2025 00:44:32

Palisade Bio, Inc. (NASDAQ:PALI) ("Palisade" or the "Company"), a clinical-stage biopharmaceutical company focu...

palisade-bio-announces-topline-results-from-phase-1-studies-of-pali-2108-phase-1-program-met-primary-endpoints-of-safety-tolerability-and-pharmacokinetics
Palisade Bio Announces Topline Results Fro...
05/27/2025 12:36:06

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION